key: cord-0853320-xgnyfzsj authors: Du, Wei‐Na; Zhang, Ying; Yu, Yong; Zhang, Ru‐Min title: D‐dimer levels is associated with severe COVID‐19 infections: A meta‐analysis date: 2021-02-17 journal: Int J Clin Pract DOI: 10.1111/ijcp.14031 sha: 79dd5e7d25ada39c4f5b5fae9b749263536ce19b doc_id: 853320 cord_uid: xgnyfzsj OBJECTIVE: The ongoing pandemic of COVID‐19 caused by the novel coronavirus Syndrome‐Coronavirus‐2 (SARS‐CoV‐2) is an emerging, rapidly evolving situation. Excluded typical manifestation of pneumonia and acute respiratory symptoms, COVID‐19 patients also have abnormal D‐dimer concentration in the serum, but the results are controversial. METHOD: A meta‐analysis first aims to explored the connection between D‐dimer concentration and COVID‐19 patients. RESULTS: Our results found a significant relationship between D‐dimer and COVID‐19, with a pooled OR of 1.90 (95% CI: 1.32‐2.48; P < .001). The pooled data were calculated with the REM as a high heterogeneity within the studies. The sensitivity analysis results showed that the WMD ranged from 1.69 (95% CI: 1.15 to 2.23) to 2.06 (95% CI: 1.51 to 2.62) and there was no publication bias. CONCLUSIONS: Our meta‐analysis showed that the severity of patients with COVID‐19 significance related to D‐dimer concentrations. Meanwhile, the severe COVID‐19 patients tend to have a higher concentration of D‐dimer when compared with non‐severe patients. REVIEW CRITERIA: We used MASH word and searched the online database and followed the inclusion and exclusion standard. The detailed information can be found in the text. MESSAGE FOR THE CLINIC: Our meta‐analysis showed that the severity of patients with COVID‐19 significance related to D‐dimer concentrations. This may be helpful for the clinic COVID‐19 patients. study indicated that D-dimer greater than 2.0 μg/mL at admission can effectively predict the hospital mortality of COVID-19 patients, with a sensitivity of 92.3% and a specificity of 83.3%. 5 However, Lei et al 6 found that D-dimer levels were not significant between intensive care unit (ICU) and non-ICU COVID-19 patients (P = .99). Therefore, this meta-analysis aims to explore the possible clinical severity between D-dimer concentration and COVID-19, and analysis if infected patients with abnormal D-dimer are particularly likely to have the worst clinical prognostic risk and to evaluate the strength of the evidence. The preferred describing items for meta-analyses (PRISMA) guidelines were used. We determined to include studies involving in coronavirus', 'D-dimer', 'feature' and 'Characteristics'. Papers were searched in the databases up to 18 April 2020, and off restrict of language. We also reviewed reference lists based on the recognised literature to find additional eligible studied. We first screened both the titles and abstracts of the articles, and publications which may involve in data concerning COVID-19 or SARS-CoV-2 and D-dimer. Primitive studies were carefully examined, and there were no nation restrictions in our study. The inclusion standard was as follows: (a) all studies reporting data on COVID-19 and laboratory-confirmed COVID-19 patients; and (b) studies were limited to mankind, contained original data, published in English and appeared in either abstract form or full-text. The exclusion standard was as follows: (a) duplicate studies, letters, case reports, abstracts, and reviews; (b) patients that may affect the fibrinolytic system, such as severe blood diseases. We collected the following information from each study: publication year, first author's name, sample size, age and D-dimer for both severe group and non-severe group. We assessed the quality of each involved research by the Newcastle-Ottawa Scale. Meta-analysis was conducted via Review Manager 5.3. We calculated the I 2 index to evaluate the heterogeneity. An I 2 value of <25%, 25%-50%, 50%-75% and 75%-100% was considered as homogeneous, low, moderate and high heterogeneity level respectively. If the I 2 value >50%, the random Overall 623 potentially relevant articles identified using our search strategy from databases and 2 from reference lists. A total of 514 studies remained after ruling out duplicates. After screening the titles and abstracts led us to rule out 466 researches that did not satisfied the inclusion criteria. After scanning the whole main body of the reserving 48 records, another 38 articles were excluded. Finally, 10 qualified articles met the eligibility criteria. 6, [8] [9] [10] [11] [12] [13] [14] [15] [16] The steps of document retrieval are shown in Figure 1 , meanwhile, the characteristic of included studies is listed in Table 1 . The meta-analysis involved overall 1430 cases (378 severe and 1052 non-severe) and all published in 2020. The clinical severity was defined as the composite of ICU admission in three studies. 6, 11, 15 Four studies defined clinical severity as the non-survivors. [8] [9] [10] 16 All articles are of high quality because of NOS score no less than 6. The forest plot outcome for the connection between D-dimer and the severity of patients with COVID-19 can be found in Figure 2 . Our results showed a significant relationship between D-dimer and COVID-19, with a pooled odds ratio (OR) of 1.90 (95% CI: 1.32-2.48; P < .001). The pooled data were calculated with the REM as a high heterogeneity within the studies. Meanwhile, our study demonstrated high heterogeneity, so we next used subgroup analysis to determine the sources of heterogeneity. We found some potential sources of heterogeneity involved in age and the number of non-severe/severe; the detailed information is shown in indicates no significant publication bias in our meta-analysis. Our meta-analysis suggests that patients with COVID-19 was significantly related to D-dimer concentration (OR = 1.90, 95% CI: 1.32-2.48; P < .001). However, our study indicates that a high heterogeneity exists within the studies. Therefore, we conducted subgroup analyses to find the sources of heterogeneity. In addition, sensitivity analysis revealed that when any single study was excluded or after REM was converted into FEM, the total outcomes yet held. So, we are confident in the data obtained in our study showing that a powerful correlation exists between D-dimer and the severity of patients with COVID-19. According to reports, among COVID-19 patients requiring hospitalisation, elevated D-dimer is one of the most common laboratory Compared with younger patients, patients aged 65 and over have higher initial comorbidities, more severe symptoms and are more prone to multiple organ involvement and death. 18 The forest plot outcome for the connection between D-dimer and the severe of patients with COVID-19 Our meta-analysis showed that the severity of patients with COVID-19 significance related to D-dimer concentrations. Meanwhile, the severe COVID-19 patients tend to have a higher concentration of D-dimer when compared with non-severe patients. This work is not supported by grants. There are no conflicts of interest. YY and YZ designed and analyzed the research study; YY and W-ND wrote and revised the manuscript, R-MZ collected the data and all authors have read and approved the manuscript. Yong Yu https://orcid.org/0000-0002-5055-4293 Ru-Min Zhang https://orcid.org/0000-0002-8308-5948 The species Severe acute respiratory syndrome related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword? Use of D-dimer in oral anticoagulation therapy D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Estimating the mean and variance from the median, range, and the size of a sample Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China Clinical features and treatment of COVID-19 patients in northeast Chongqing Clinical and immunological features of severe and moderate coronavirus disease 2019 Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Clinical characteristics of coronavirus disease 2019 in China Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes D-dimer levels is associated with severe COVID-19 infections: A meta-analysis